TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors
Brief Summary: The current study proposes to study the feasibility and acceptability of a brief psychosocial intervention delivered to suicide attempt survivors hospitalized on a medical/surgical floor or inpatient psychiatry unit at Vanderbilt University Medical Center. The proposed study will involve training of care providers affiliated with Vanderbilt University Medical Center to deliver the brief intervention. Additionally, the participants will complete baseline, 1, 3, and 12-month assessments on outcomes of interest, including readiness to change problematic behaviors, engagement in outpatient mental health services, suicidal ideation, self-harming behavior, and reasons for living.


Options:
A: Arm Label: CAMS treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Psychotherapy | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychotherapy | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): CAMS treatment, Treatment as usual
B: Arm Label: ASSIP + TAU goup; Type: EXPERIMENTAL; Interventions: Other: ASSIP | Arm Label: TAU; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: ASSIP; Assigned to Arm(s): ASSIP + TAU goup
C: Arm Label: Care as Usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention; Assigned to Arm(s): Teachable Moment Brief Intervention
D: Arm Label: 20 weeks skills group; Type: EXPERIMENTAL; Interventions: Behavioral: Skills Training | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Skills Training; Assigned to Arm(s): 20 weeks skills group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors
Brief Summary: The current study proposes to study the feasibility and acceptability of a brief psychosocial intervention delivered to suicide attempt survivors hospitalized on a medical/surgical floor or inpatient psychiatry unit at Vanderbilt University Medical Center. The proposed study will involve training of care providers affiliated with Vanderbilt University Medical Center to deliver the brief intervention. Additionally, the participants will complete baseline, 1, 3, and 12-month assessments on outcomes of interest, including readiness to change problematic behaviors, engagement in outpatient mental health services, suicidal ideation, self-harming behavior, and reasons for living.


Options:
A: Arm Label: Study participants; Type: EXPERIMENTAL; Interventions: Other: EMA | Intervention Type: OTHER; Name: EMA; Assigned to Arm(s): Study participants
B: Arm Label: Care as Usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention; Assigned to Arm(s): Teachable Moment Brief Intervention
C: Arm Label: CHESS Mobile Health Group; Type: EXPERIMENTAL; Interventions: Device: CHESS Mobile Health smart phone application, Behavioral: Problem solving therapy | Intervention Type: DEVICE; Name: CHESS Mobile Health smart phone application; Assigned to Arm(s): CHESS Mobile Health Group | Intervention Type: BEHAVIORAL; Name: Problem solving therapy; Assigned to Arm(s): CHESS Mobile Health Group
D: Arm Label: Youth culturally adapted therapy (Y-CMAP); Type: EXPERIMENTAL; Interventions: Behavioral: Youth Culturally Adapted Manual Assisted Psychological Therapy (Y-CMAP) | Arm Label: Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Youth Culturally Adapted Manual Assisted Psychological Therapy (Y-CMAP); Assigned to Arm(s): Youth culturally adapted therapy (Y-CMAP)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis
Brief Summary: For elective abdominal surgery preoperative administration of 8 mg dexamethasone reduces the incidents of postoperative nausea and vomiting (PONV). Whether preoperative administration of 8 mg dexamethasone reduces PONV for patients having acute abdominal surgery has not been established. The investigators wish to see if preoperative administration of 8 mg dexamethasone minimum 30 minutes prior to a diagnostic laparoscopy for suspected appendicitis will reduce the incidents of PONV by 50%. Of secondary interest the investigators want to see if 8 mg dexamethasone preoperative can reduce pain, reduce opioid consumption, postoperative fatigue, duration of time until resumption of work and resumption of normal daily activities, and enhanced the quality of recovery.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Isotonic NaCl | Arm Label: dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: dexamethasone phosphate | Intervention Type: DRUG; Name: dexamethasone phosphate; Assigned to Arm(s): dexamethasone | Intervention Type: DRUG; Name: Isotonic NaCl; Assigned to Arm(s): Placebo
B: Arm Label: Acustimulation; Type: EXPERIMENTAL; Interventions: Device: Transcutaneous electrical acupoint stimulation, Drug: Dexamethasone | Arm Label: Tropisetron; Type: ACTIVE_COMPARATOR; Interventions: Device: Sham transcutaneous electrical acupoint stimulation, Drug: Tropisetron, Drug: Dexamethasone | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: Sham transcutaneous electrical acupoint stimulation, Drug: Dexamethasone | Intervention Type: DEVICE; Name: Transcutaneous electrical acupoint stimulation; Assigned to Arm(s): Acustimulation | Intervention Type: DEVICE; Name: Sham transcutaneous electrical acupoint stimulation; Assigned to Arm(s): Control, Tropisetron | Intervention Type: DRUG; Name: Tropisetron; Assigned to Arm(s): Tropisetron | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Acustimulation, Control, Tropisetron
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: GW679769 (casopitant) | Intervention Type: DRUG; Name: GW679769 (casopitant); Assigned to Arm(s): Arm 1
D: Arm Label: Aprepitant group; Type: EXPERIMENTAL; Interventions: Drug: Aprepitant | Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Aprepitant; Assigned to Arm(s): Aprepitant group | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 'URSA SOFT CAP. (UDCA-003)' in fatigue patients with liver dysfunction


Options:
A: Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): N/A
B: Arm Label: Pentoxifylline; Type: EXPERIMENTAL; Interventions: Drug: Pentoxifylline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Pentoxifylline; Assigned to Arm(s): Pentoxifylline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: MRI(+ve),; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: 200mg of Palm vitamin E (tocotrienols) or placebo | Arm Label: MRI(-ve); Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: 200mg of Palm vitamin E (tocotrienols) or placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: 200mg of Palm vitamin E (tocotrienols) or placebo; Assigned to Arm(s): MRI(+ve),, MRI(-ve)
D: Arm Label: udca003; Type: EXPERIMENTAL; Interventions: Drug: Ursodeoxycholic acid, thiamine, riboflavin | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ursodeoxycholic acid, thiamine, riboflavin | Intervention Type: DRUG; Name: Ursodeoxycholic acid, thiamine, riboflavin; Assigned to Arm(s): placebo, udca003

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating Child Protective Effects of Economic Strengthening and Child Rights Interventions Among Ultra-poor Families in Burkina Faso
Brief Summary: This study tests the effects of family-based economic empowerment intervention, alone and in combination with child rights sensitization component, on child protective outcomes among ultra-poor families in Nord Region, Burkina Faso.


Options:
A: Arm Label: Trickle Up; Type: EXPERIMENTAL; Interventions: Behavioral: Trickle Up | Arm Label: Trickle Up Plus; Type: EXPERIMENTAL; Interventions: Behavioral: Trickle Up Plus | Arm Label: Wait-list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trickle Up; Assigned to Arm(s): Trickle Up | Intervention Type: BEHAVIORAL; Name: Trickle Up Plus; Assigned to Arm(s): Trickle Up Plus
B: Arm Label: Empateach Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Empateach | Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Empateach; Assigned to Arm(s): Empateach Intervention
C: Arm Label: Parenting Program; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting Program | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Parenting Program; Assigned to Arm(s): Parenting Program
D: Arm Label: Specialty Care; Type: ACTIVE_COMPARATOR; Interventions: Other: psychiatric medications and evidence-based psychotherapies | Arm Label: Integrated Care; Type: EXPERIMENTAL; Interventions: Other: psychiatric medications and evidence-based psychotherapies | Arm Label: Community Clinic Stepped Care; Type: EXPERIMENTAL; Interventions: Other: psychiatric medications and evidence-based psychotherapies | Intervention Type: OTHER; Name: psychiatric medications and evidence-based psychotherapies; Assigned to Arm(s): Community Clinic Stepped Care, Integrated Care, Specialty Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Brief Summary: The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.


Options:
A: Arm Label: Chantix; Type: EXPERIMENTAL; Interventions: Drug: Chantix, Drug: Nicotine patches | Arm Label: Chantix + Zyban; Type: EXPERIMENTAL; Interventions: Drug: Chantix, Drug: Zyban, Drug: Nicotine patches | Intervention Type: DRUG; Name: Chantix; Assigned to Arm(s): Chantix, Chantix + Zyban | Intervention Type: DRUG; Name: Zyban; Assigned to Arm(s): Chantix + Zyban | Intervention Type: DRUG; Name: Nicotine patches; Assigned to Arm(s): Chantix, Chantix + Zyban
B: Arm Label: Assessment Only (ASSESS); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Self-Help (GENERIC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GENERIC | Arm Label: Targeted Self-Help (eTARGET); Type: EXPERIMENTAL; Interventions: Behavioral: eTARGET | Intervention Type: BEHAVIORAL; Name: GENERIC; Assigned to Arm(s): Generic Self-Help (GENERIC) | Intervention Type: BEHAVIORAL; Name: eTARGET; Assigned to Arm(s): Targeted Self-Help (eTARGET)
C: Arm Label: Healthy Control - Non-smoking; Type: OTHER; Interventions: Other: Biological Control | Arm Label: Healthy Control - Smoker; Type: OTHER; Interventions: Other: Biological Control | Arm Label: HIV Smoking Cessation Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline tartrate, Drug: Nicotine Replacement Therapy | Arm Label: Motivational Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interview | Intervention Type: DRUG; Name: Varenicline tartrate; Assigned to Arm(s): HIV Smoking Cessation Arm | Intervention Type: DRUG; Name: Nicotine Replacement Therapy; Assigned to Arm(s): HIV Smoking Cessation Arm | Intervention Type: OTHER; Name: Biological Control; Assigned to Arm(s): Healthy Control - Non-smoking, Healthy Control - Smoker | Intervention Type: BEHAVIORAL; Name: Motivational Interview; Assigned to Arm(s): Motivational Intervention
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Brief Summary: The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.


Options:
A: Arm Label: Standard Arm (Arm A); Type: ACTIVE_COMPARATOR; Interventions: Other: TOBACCO CIGARETTES | Arm Label: Intervention Arm (Arm B); Type: ACTIVE_COMPARATOR; Interventions: Other: COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS) | Intervention Type: OTHER; Name: TOBACCO CIGARETTES; Assigned to Arm(s): Standard Arm (Arm A) | Intervention Type: OTHER; Name: COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS); Assigned to Arm(s): Intervention Arm (Arm B)
B: Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Treatment Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: varenicline (CP-526,555) | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo Arm | Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): Treatment Arm
C: Arm Label: Assessment Only (ASSESS); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Self-Help (GENERIC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GENERIC | Arm Label: Targeted Self-Help (eTARGET); Type: EXPERIMENTAL; Interventions: Behavioral: eTARGET | Intervention Type: BEHAVIORAL; Name: GENERIC; Assigned to Arm(s): Generic Self-Help (GENERIC) | Intervention Type: BEHAVIORAL; Name: eTARGET; Assigned to Arm(s): Targeted Self-Help (eTARGET)
D: Arm Label: The STOP intervention; Type: EXPERIMENTAL; Interventions: Other: The STOP intervention | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Care | Intervention Type: OTHER; Name: The STOP intervention; Assigned to Arm(s): The STOP intervention | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Brief Summary: The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.


Options:
A: Arm Label: The STOP intervention; Type: EXPERIMENTAL; Interventions: Other: The STOP intervention | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Care | Intervention Type: OTHER; Name: The STOP intervention; Assigned to Arm(s): The STOP intervention | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
B: Arm Label: IQOS; Type: EXPERIMENTAL; Interventions: Device: IQOS | Arm Label: E-CIG; Type: ACTIVE_COMPARATOR; Interventions: Device: E-CIG | Intervention Type: DEVICE; Name: IQOS; Assigned to Arm(s): IQOS | Intervention Type: DEVICE; Name: E-CIG; Assigned to Arm(s): E-CIG
C: Arm Label: Assessment Only (ASSESS); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Self-Help (GENERIC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GENERIC | Arm Label: Targeted Self-Help (eTARGET); Type: EXPERIMENTAL; Interventions: Behavioral: eTARGET | Intervention Type: BEHAVIORAL; Name: GENERIC; Assigned to Arm(s): Generic Self-Help (GENERIC) | Intervention Type: BEHAVIORAL; Name: eTARGET; Assigned to Arm(s): Targeted Self-Help (eTARGET)
D: Arm Label: Electronic cigarette with or without nicotine; Type: ACTIVE_COMPARATOR; Interventions: Other: Electronic cigarette | Arm Label: Smoker control; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional cigarette | Intervention Type: OTHER; Name: Electronic cigarette; Assigned to Arm(s): Electronic cigarette with or without nicotine | Intervention Type: OTHER; Name: Conventional cigarette; Assigned to Arm(s): Smoker control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Brief Summary: The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.


Options:
A: Arm Label: Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: NH Medicaid Incentives Program | Arm Label: No Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: NH Medicaid Incentives Program | Intervention Type: BEHAVIORAL; Name: NH Medicaid Incentives Program; Assigned to Arm(s): Incentives, No Incentives
B: Arm Label: E-Cigarette; Type: EXPERIMENTAL; Interventions: Other: E-Cigarette Vs. Smoking as Usual | Arm Label: Assessment Only; Type: ACTIVE_COMPARATOR; Interventions: Other: E-Cigarette Vs. Smoking as Usual | Intervention Type: OTHER; Name: E-Cigarette Vs. Smoking as Usual; Assigned to Arm(s): Assessment Only, E-Cigarette
C: Arm Label: Electronic cigarette condition; Type: EXPERIMENTAL; Interventions: Drug: Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline | Arm Label: Varenicline condition; Type: ACTIVE_COMPARATOR; Interventions: Drug: Electronic cigarette without nicotine (ECwN) plus active varenicline tablets | Arm Label: Placebo condition; Type: PLACEBO_COMPARATOR; Interventions: Drug: Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline | Intervention Type: DRUG; Name: Electronic cigarette without nicotine (ECwN) plus active varenicline tablets; Assigned to Arm(s): Varenicline condition | Intervention Type: DRUG; Name: Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline; Assigned to Arm(s): Placebo condition | Intervention Type: DRUG; Name: Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline; Assigned to Arm(s): Electronic cigarette condition
D: Arm Label: Assessment Only (ASSESS); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Self-Help (GENERIC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GENERIC | Arm Label: Targeted Self-Help (eTARGET); Type: EXPERIMENTAL; Interventions: Behavioral: eTARGET | Intervention Type: BEHAVIORAL; Name: GENERIC; Assigned to Arm(s): Generic Self-Help (GENERIC) | Intervention Type: BEHAVIORAL; Name: eTARGET; Assigned to Arm(s): Targeted Self-Help (eTARGET)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tampostat: A Low-cost, Self-regulating Tamponade for Management of Postpartum Hemorrhage in Bangladesh
Brief Summary: The purpose of the study is to evaluate the safety, feasibility and applicability of a new device 'Tampostat' in the management of primary postpartum hemorrhage and compare the efficacy of 'Tampostat' in terms of arresting primary PPH with that of the conventional condom catheter.


Options:
A: Arm Label: Tampostat; Type: EXPERIMENTAL; Interventions: Device: Tampostat | Arm Label: Condom catheter tamponade; Type: ACTIVE_COMPARATOR; Interventions: Device: Condom catheter tamponade | Intervention Type: DEVICE; Name: Tampostat; Assigned to Arm(s): Tampostat | Intervention Type: DEVICE; Name: Condom catheter tamponade; Assigned to Arm(s): Condom catheter tamponade
B: Arm Label: Baseline period; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Uterine balloon tamponade; Type: EXPERIMENTAL; Interventions: Other: Uterine balloon tamponade | Intervention Type: OTHER; Name: Uterine balloon tamponade; Assigned to Arm(s): Uterine balloon tamponade
C: Arm Label: B-Lynch; Type: ACTIVE_COMPARATOR; Interventions: Procedure: B-Lynch | Arm Label: Bakri balloon; Type: ACTIVE_COMPARATOR; Interventions: Procedure: BALLOON INSERTION | Intervention Type: PROCEDURE; Name: B-Lynch; Assigned to Arm(s): B-Lynch | Intervention Type: PROCEDURE; Name: BALLOON INSERTION; Assigned to Arm(s): Bakri balloon
D: Arm Label: Bakri Balloon with abdominal traction stitch; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal traction stitch, Device: Bakri Balloon | Arm Label: Bakri Balloon without abdominal traction stitch; Type: EXPERIMENTAL; Interventions: Device: Bakri Balloon | Intervention Type: PROCEDURE; Name: Abdominal traction stitch; Assigned to Arm(s): Bakri Balloon with abdominal traction stitch | Intervention Type: DEVICE; Name: Bakri Balloon; Assigned to Arm(s): Bakri Balloon with abdominal traction stitch, Bakri Balloon without abdominal traction stitch

Answer: A